International journal of cardiology. Heart & vasculature · 2026
The association between angiographic stenosis characteristics and surgical treatment in diffuse LAD disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Betti Matteo, Bova Roberto, Heuts Samuel, Vriesendorp Pieter A, Ijsselmuiden Alexander J J, Rasoul Saman, Ilhan Mustafa, Vainer Jindra, Theunissen Ralph A L J, Veenstra Leo F, Maaroufi Anass, Slegers Daniek P J, Hof Arnoud W J van 't, Lux Arpad
Аннотация
BACKGROUND: Intracoronary pressure-wire pullback allows differentiation between focal and diffuse disease, improving precision of revascularisation strategies. While focal lesions benefit from percutaneous coronary intervention (PCI), diffuse disease yields suboptimal results and is therefore treated with coronary artery bypass grafting (CABG) or conservatively (i.e., optimal medical therapy [OMT]). Current guidelines emphasise the prognostic relevance of proximal left anterior descending artery (LAD) disease, yet its role in guiding treatment in diffuse disease remains uncertain.
OBJECTIVES: To evaluate whether angiographically severe proximal LAD disease influences revascularisation strategy in functionally significant diffuse LAD disease.
METHODS: This retrospective cohort study included patients undergoing coronary angiography and subsequent pullback measurement in the LAD in the presence of ischemia (FFR ≤0.80 or RFR ≤0.89), between 2022 and 2024. Coronary anatomy was reassessed blinded to treatment. Multinomial logistic regression explored predictors of treatment strategy (OMT, PCI, or CABG) in patients with diffuse LAD disease.
RESULTS: Among 303 patients with significant LAD disease, 214 (71%) had diffuse and 89 (29%) focal disease. Baseline characteristics were similar. Focal disease was more associated with triple-vessel CAD (34% vs. 19%; p = 0.007). Severe proximal (21% vs. 7.9%; p = 0.004) and distal LAD stenosis were more common in diffuse disease. In diffuse disease only, severe proximal LAD was associated with an increase in CABG (28.3% vs. 10.1%; p = 0.004) and a decrease in OMT rates (54.3% vs. 75.6%; p = 0.009). Multinomial regression confirmed this association (OR 0.26; p = 0.003).
CONCLUSION: Absence of angiographically severe proximal LAD stenosis is associated with CABG deferral in diffuse, functionally significant LAD disease.
OBJECTIVES: To evaluate whether angiographically severe proximal LAD disease influences revascularisation strategy in functionally significant diffuse LAD disease.
METHODS: This retrospective cohort study included patients undergoing coronary angiography and subsequent pullback measurement in the LAD in the presence of ischemia (FFR ≤0.80 or RFR ≤0.89), between 2022 and 2024. Coronary anatomy was reassessed blinded to treatment. Multinomial logistic regression explored predictors of treatment strategy (OMT, PCI, or CABG) in patients with diffuse LAD disease.
RESULTS: Among 303 patients with significant LAD disease, 214 (71%) had diffuse and 89 (29%) focal disease. Baseline characteristics were similar. Focal disease was more associated with triple-vessel CAD (34% vs. 19%; p = 0.007). Severe proximal (21% vs. 7.9%; p = 0.004) and distal LAD stenosis were more common in diffuse disease. In diffuse disease only, severe proximal LAD was associated with an increase in CABG (28.3% vs. 10.1%; p = 0.004) and a decrease in OMT rates (54.3% vs. 75.6%; p = 0.009). Multinomial regression confirmed this association (OR 0.26; p = 0.003).
CONCLUSION: Absence of angiographically severe proximal LAD stenosis is associated with CABG deferral in diffuse, functionally significant LAD disease.